TransBioLine Consortium met in Sitges, Barcelona, on the 30th September and 1st October 2019.
Members of the 27 partners of the Consortium met in Sitges to report on progress during the first half year of the project life as well as to discuss on project specific topics as Patient recruitment, Data and first validation assays tasks.
The 2 day meeting held around sample and data workflow workshops. Considered progress has been made during the first 6 months of the project. First studies have been approved, and first patients recruited. The consortium counted with the presence of the valuable feedback from the Scientific Advisor (SAB) Patrick Murray, from the University College of Dublin, and the Ethics advisor (EAB) Magnus Ingelman Sundberg, from Karolinska Institute.